In tumor immunology, it is generally believed that Th1 cells are often critical components in anti-tumor immune responses due to their ability to produce IFN-γ, activate macrophages, and boost the killer CD8+ T-cells, whereas type 2 helper responses can promote cancer development or metastasis [24]. Here, CD8A is linked to neoplasm.